早期治疗通气预测肺癌光子与质子放疗末通气反应
该研究纳入71例肺癌患者(48例光子放疗、23例质子放疗),基于4D-CT生成计划时、治疗初期(BOT)和治疗结束时(EOT)的通气图,分析BOT通气变化能否预测EOT通气变化。结果显示BOT通气增加者中74%在EOT分层一致,BOT通气减少者中85%在EOT分层一致;仅计划通气、BOT通气和肺体积与EOT通气相关,线性回归模型R²为0.89。
要点
- BOT通气变化可预测EOT通气变化,提示通气可作为影像生物标志物。
- BOT通气增加者74%在EOT分层一致,减少者85%一致。
- 仅计划通气、BOT通气和肺体积与EOT通气相关,模型R²=0.89。
核心结论
- 治疗初期(BOT)的通气变化能够预测治疗结束时(EOT)的通气变化,通气作为影像生物标志物具有较大潜力。
研究设计与样本
- 研究纳入71例肺癌患者,其中48例接受光子放疗、23例接受质子放疗,在计划时、BOT和EOT生成基于4D-CT的通气图。
- 按治疗方式(合并及分开)和BOT通气增减将患者分为6组,逐体素计算BOT和EOT通气变化,并按计划剂量分箱计算中位数。
- 采用单因素分析EOT通气与计划通气、BOT通气及临床因素的相关性,并建立线性回归模型预测EOT通气,以R²评估模型精度。
主要发现
- BOT通气增加的患者中,74%(光子79%、质子75%)在EOT分层一致。
- BOT通气减少的患者中,85%(光子86%、质子82%)在EOT分层一致。
- 单因素分析显示仅计划通气、BOT通气和肺体积与EOT通气相关。
- 线性回归模型预测EOT通气的R²为0.89。
临床怎么用
- 可利用治疗早期通气变化预判治疗结束时通气变化,辅助功能肺避让放疗的个体化调整。
- 通气变化作为影像生物标志物,有待与患者报告结局和放射性肺炎等毒性进一步关联。
局限性
- 研究样本量有限(71例),需更大样本验证。
- 尚未将通气变化与患者报告结局及放射性肺炎等毒性进行关联分析。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: Functional lung avoidance radiation therapy (RT) spares high-functioning regions of the lung to reduce toxicity risk but disregards functional changes during treatment. To further investigate functional changes in the normal lung, we employ voxel-based techniques, including ventilation maps, throughout treatment. We hypothesize that ventilation change during the beginning of treatment (BOT) predicts ventilation change between planning and the end of treatment (EOT). METHODS AND MATERIALS: For 71 patients with lung cancer, 48 treated with photon RT and 23 treated with proton RT, 4-dimensional CT-based ventilation maps were generated using stress-based finite-element methods at planning, BOT, and EOT. Voxelwise ventilation change at BOT and EOT was calculated. Patients were stratified into 6 groups according to modality (combined and separate) and increased or decreased ventilation at BOT. For each group, ventilation change was binned by planned dose, and the median was computed at BOT and EOT across patients. EOT ventilation was correlated with planning ventilation, BOT ventilation, and clinical factors through univariate analysis. A linear regression model was developed to identify predictors of EOT ventilation. Model features included ventilation at planning, ventilation at BOT, and lung volume. Model accuracy was assessed through R2. RESULTS: Of the patients with increased ventilation at BOT, 74% (79% of photon patients and 75% of proton patients) were stratified identically at EOT. Of the patients with decreased ventilation at BOT, 85% (86% of photon patients and 82% of proton patients) were stratified identically at EOT. Univariate analysis indicated that only planning ventilation, BOT ventilation, and lung volume were correlated with EOT ventilation. The linear regression model achieved an R2 of 0.89. CONCLUSION: Ventilation change at BOT can predict ventilation change at EOT, demonstrating great potential for using ventilation as an imaging biomarker. Further work is needed to correlate ventilation change with patient-reported outcomes and radiation-induced toxicities such as pneumonitis.
引用
- Lim R, O'Connor CS, Pan J, et al. Predicting End-of-Treatment Ventilation Response to Radiation Therapy Using Early Treatment Ventilation for Patients With Lung Cancer Treated With Photons and Protons. Int J Radiat Oncol Biol Phys. 2026. PMID: 42520860. doi:10.1016/j.ijrobp.2026.07.026
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。